Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Hoffer

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|October 1, 1991
[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brainJ L Neumeyer, S Y Wang, R A Milius, et al.
Nuclear Medicine and Biology|April 8, 2000
[123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primatesB E Scanley, M S Gandelman, M Laruelle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
SPECT imaging of striatal dopamine release after amphetamine challengeM Laruelle, A Abi-Dargham, C H van Dyck, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1994
SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experimentsM Laruelle, R M Baldwin, Z Rattner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's diseaseC H van Dyck, C H Lin, E O Smith, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECTC H van Dyck, J P Seibyl, R T Malison, et al.
European Journal of Nuclear Medicine|January 1, 1995
Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primatesB E Scanley, M S al-Tikriti, M S Gandelman, et al.
Nuclear Medicine and Biology|January 1, 1996
Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBFC H van Dyck, J P Seibyl, J B Stubbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjectsM Laruelle, C van Dyck, A Abi-Dargham, et al.
Synapse (New York, N.Y.)|March 1, 1992
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primatesR B Innis, R T Malison, M al-Tikriti, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|October 1, 1991
[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brainJ L Neumeyer, S Y Wang, R A Milius, et al.
Nuclear Medicine and Biology|April 8, 2000
[123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primatesB E Scanley, M S Gandelman, M Laruelle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
SPECT imaging of striatal dopamine release after amphetamine challengeM Laruelle, A Abi-Dargham, C H van Dyck, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 1, 1994
SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experimentsM Laruelle, R M Baldwin, Z Rattner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's diseaseC H van Dyck, C H Lin, E O Smith, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECTC H van Dyck, J P Seibyl, R T Malison, et al.
European Journal of Nuclear Medicine|January 1, 1995
Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primatesB E Scanley, M S al-Tikriti, M S Gandelman, et al.
Nuclear Medicine and Biology|January 1, 1996
Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBFC H van Dyck, J P Seibyl, J B Stubbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjectsM Laruelle, C van Dyck, A Abi-Dargham, et al.
Synapse (New York, N.Y.)|March 1, 1992
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primatesR B Innis, R T Malison, M al-Tikriti, et al.
Pageof 15